Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - clarithromycin - film-coated tablet - 250 milligram(s) - macrolides; clarithromycin

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - clarithromycin (unii: h1250jik0a) (clarithromycin - unii:h1250jik0a) - clarithromycin 250 mg - clarithromycin tablets usp are indicated for the treatment of mild to moderate infections caused by susceptible isolates of the designated bacteria in the conditions as listed below: pharyngitis/tonsillitis due to streptococcus pyogenes (the usual drug of choice in the treatment and prevention of streptococcal infections and the prophylaxis of rheumatic fever is penicillin administered by either the intramuscular or the oral route. clarithromycin is generally effective in the eradication of s. pyogenes from the nasopharynx; however, data establishing the efficacy of clarithromycin in the subsequent prevention of rheumatic fever are not available at present). acute maxillary sinusitis due to haemophilus influenzae , moraxella catarrhalis , or streptococcus pneumoniae . acute bacterial exacerbation of chronic bronchitis due to haemophilus influenzae , haemophilus parainfluenzae , moraxella catarrhalis , or streptococcus pneumoniae . community-acquired pneumonia due to haemophilus influenzae , mycoplasma pneum

Canada - English - Health Canada

teva canada limited - clarithromycin - tablet - 250mg - clarithromycin 250mg - other macrolides

Canada - English - Health Canada

teva canada limited - clarithromycin - tablet - 500mg - clarithromycin 500mg - other macrolides

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - clarithromycine 500 mg - film-coated tablet - 500 mg - clarithromycine 500 mg - clarithromycin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - clarithromycine 250 mg - film-coated tablet - 250 mg - clarithromycine 250 mg - clarithromycin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - clarithromycin - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - clarithromycin - oral tablet - 500mg

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - clarithromycin (unii: h1250jik0a) (clarithromycin - unii:h1250jik0a) - clarithromycin 500 mg